Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 51,139 | 48,430 | 47,769 | 46,688 | 44,373 |
| Cost of Goods | 1,189 | 1,494 | 1,370 | 1,725 | 1,513 |
| Gross Profit | 49,950 | 46,936 | 46,399 | 44,963 | 42,860 |
| Operating Expenses | 69,574 | 70,541 | 61,836 | 73,855 | 77,810 |
| Operating Income | -19,435 | -23,111 | -15,067 | -28,167 | -34,437 |
| Interest Expense | 4,767 | 4,634 | 4,887 | 4,599 | 4,547 |
| Other Income | 1,676 | 1,742 | 1,786 | 2,539 | 1,971 |
| Pre-tax Income | -22,526 | -26,003 | -18,168 | -30,227 | -37,013 |
| Income Tax | 23 | 65 | -18,976 | 32 | -523 |
| Net Income Continuous | -22,549 | -26,068 | 808 | -30,259 | -36,490 |
| Net Income | $-22,549 | $-26,068 | $808 | $-30,259 | $-36,490 |
| EPS Basic Total Ops | -0.44 | -0.58 | 0.02 | -0.70 | -0.85 |
| EPS Basic Continuous Ops | -0.44 | -0.58 | 0.02 | -0.70 | -0.85 |
| EPS Diluted Total Ops | -0.44 | -0.58 | 0.02 | -0.70 | -0.85 |
| EPS Diluted Continuous Ops | -0.44 | -0.58 | 0.02 | -0.70 | -0.85 |
| EBITDA(a) | $-10,161 | $-14,465 | $-6,722 | $5,120 | $-26,796 |